ETFS Holding Viropharma, Inc.

 
News Articles for Viropharma, Inc. top ^
EXTON, Pa.
Sign-up for ViroPharma Announces Second Quarter 2013 Financial Results investment picks
2013/9/9
EXTON, Pa.
Sign-up for ViroPharma To Participate In The Stifel Nicolaus 2013 Healthcare Conference investment picks
2013/10/31
- Cinryze® (C1 Esterase Inhibitor [Human]) North American Net Sales Guidance Raised to $395 to $405 Million - EXTON, Pa.
Sign-up for ViroPharma Incorporated Reports Third Quarter 2013 Financial Results investment picks
2013/11/12
The Young Law Firm , a national shareholder litigation firm, is investigating potential claims concerning the proposed acquisition of ViroPharma Incorporated (“ViroPharma” or the “Company”) (Nasdaq: VPHM ) by Shire plc .
Sign-up for Attention VPHM Shareholders: The Proposed Buyout of ViroPharma Incorporated by Shire plc is under Investigation by The Young Law Firm investment picks
2013/11/12
Levi & Korsinsky is investigating the Board of Directors of ViroPharma, Inc. (“ViroPharma” or the “Company”) (NasdaqGS: VPHM) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Shire PLC (“Shire”). Click here to learn more about the investigation http://zlk.9nl.com/viropharmavphm/ , or call: 877-363-5972.
Sign-up for LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC investment picks
2013/11/12
WAYNE, Pa.
Sign-up for Ryan & Maniskas, LLP Announces Investigation of ViroPharma Inc. investment picks
NEW YORK , Nov.
Sign-up for Harwood Feffer LLP Announces Investigation of ViroPharma, Inc. investment picks
2013/11/11
The securities litigation firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of ViroPharma Incorporated (“ViroPharma” or the “Company”) (NASDAQ: VPHM) and other violations of state law by the board of directors of ViroPharma relating to the proposed buyout of the Company by Shire Plc.
Sign-up for SHAREHOLDER ALERT: Law Firm Brower Piven Announces Investigation of Possible Breaches of Fiduciary Duty by Directors of ViroPharma Incorporated in Connection with Proposed Buyout investment picks
The law firm of Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of ViroPharma Inc. (Nasdaq: VPHM) (“ViroPharma” or “the Company”), concerning the Company’s proposed acquisition by Shire Plc (Nasdaq: SHPG) (“Shire”). Under the terms of the proposal, ViroPharma shareholders will receive $50.00 in cash for each share of ViroPharma they own.
Sign-up for Finkelstein Thompson LLP Announces Investigation of ViroPharma Inc. Buyout Proposal investment picks
2013/11/11
Rigrodsky & Long, P.A.: Do you own shares of ViroPharma Incorporated (NASDAQ GS: VPHM )? Did you purchase any of your shares prior to November 11, 2013?
Sign-up for VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
2013/11/11
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of ViroPharma Inc. (“ViroPharma”) (NasdaqGS: VPHM) related to the acquisition by Shire PLC for shareholders.
Sign-up for ViroPharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Shire investment picks
Levi & Korsinsky is investigating the Board of Directors of ViroPharma, Inc. (“ViroPharma” or the “Company”) (NasdaqGS: VPHM) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Shire PLC (“Shire”). Click here to learn more about the investigation http://zlk.9nl.com/viropharmavphm/ , or call: 877-363-5972.
Sign-up for LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

ETFS Holding Viropharma, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding Viasat Inc  |  Next: ETFS Holding Visa, Inc.